Tietz syndrome

Also Known As:

Albinism and complete nerve deafness; Albinism-deafness of Tietz; Hypopigmentation-deafness of Tietz; Tietz albinism-deafness syndrome

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Hearing Loss (Hearing Impairment)
2.	Hypopigmentation (Hypomelanosis)

1.	Bartsch, Oliver: 1 article (03/2013)
2.	Bohring, Axel: 1 article (03/2013)
3.	Buske, Annegret: 1 article (03/2013)
4.	Graul-Neumann, Luitgard M: 1 article (03/2013)
5.	Greally, Marie: 1 article (03/2013)
6.	Kubisch, Christian: 1 article (03/2013)
7.	Steinberger, Daniela: 1 article (03/2013)
8.	Strobl-Wildemann, Gertrud: 1 article (03/2013)
9.	Suckfüll, Markus: 1 article (03/2013)
10.	Vogt, Stefanie: 1 article (03/2013)

Drugs and Important Biological Agents (IBA) related to Tietz syndrome:

1.	Microphthalmia-Associated Transcription FactorIBA 08/01/2010 - "Effect of the mutant microphthalmia-associated transcription factor found in Tietz syndrome on the in vitro development of mast cells."
2.	Nuclear Localization Signals (Nuclear Localization Signal)IBA 07/01/2008 - "Tietz syndrome: unique phenotype specific to mutations of MITF nuclear localization signal."
3.	Amino Acids FDA Link 03/18/2013 - "MITF 3-bp deletions at amino acid position 217 have previously been described in patients with Tietz syndrome (TS), a clinical entity with hearing loss and generalised hypopigmentation. "